R-Vision Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 192.36%
- Profit Growth 519.89%
- Ebitda 963.60%
- Net Worth 32.55%
- Total Assets 30.32%
About R-Vision Eye Hospital
R-Vision Eye Hospital Private Limited (REHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 February 2019 (Five years and 11 months 10 days old ). Its registered office is in Kannur, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Varsha Vaidyanath, Ramesh Hariharan, Rajimon Kolakkal, and Two other members serve as directors at the Company.
Company Details
-
Location
Kannur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KL2019PTC056944
-
Company No.
056944
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at R-Vision Eye Hospital?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramesh Hariharan | Managing Director | 22-Feb-2019 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pudugrammam Vaidyanathan | Director | 22-Feb-2019 | Current |
Varsha Vaidyanath | Director | 23-May-2021 | Current |
Rajimon Kolakkal | Director | 22-Feb-2019 | Current |
Tirunilayi Venugopal | Director | 22-Feb-2019 | Current |
Financial Performance of R-Vision Eye Hospital.
R-Vision Eye Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 192.36% increase. The company also saw a substantial improvement in profitability, with a 519.89% increase in profit. The company's net worth Soared by an impressive increase of 32.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of R-Vision Eye Hospital?
In 2020, R-Vision Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at R-Vision Eye Hospital?
Unlock and access historical data on people associated with R-Vision Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R-Vision Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R-Vision Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.